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Abstract 
 
Objectives Vascular complications are one of the most common causes of 
early kidney transplant dysfunction. Contrast enhanced ultrasound  increases 
sensitivity to tiny vascular changes.. The aim was to assess the prevalence and 
size of vascular abnormalities in renal transplantation patients following 
surgery using 3D CEUS to determine the significance of perfusion defects on 
renal function. 
 
Methods Ninety nine renal transplant patients underwent 3D CEUS after 
surgery to quantify perfusion defects as percentage total renal volume (TRV).  
Serum creatinine and estimated glomerular filtration rate (eGFR) were 
recorded up to three months post-surgery. 
 
Results In the 99 patients, 20 had perfusion defects (0.2 – 43% TRV).  There 
was a meaningful difference in patients with perfusion defects in eGFR at 1 
month (90% CI 2.7 to 19.2 ml/min/1.73m2) and 3 months (90% CI 1.9 to 19.6 
ml/min/1.73m2) and in Creatinine at 3 months (90% CI -56 to -8 μmol/L) using 
a predetermined clinical threshold. 
Perfusion defect size correlated well with both serum creatinine and eGFR at 
3 months (R= 0.80 (p ≤ 0.000) and 0.58 (p= 0.038)). No correlation seen prior 
to 3 months.   
 
Conclusions Perfusion defects in kidney transplants were more common 
than expected and were highly likely to reduce renal function at 1-3 months 
and the size of the defect affected the degree of functional change at 3 
months.  
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Keypoints:  
 Perfusion defects were more common than previously thought and 
could be quantified using 3D CEUS. 
 The presence of even small perfusion defects may affect function of 
the kidney. 
 The size of perfusion defects correlated with subsequent kidney 
function at 3 months. 
 This may be useful in informing clinician expectations of kidney 
function following surgery. 
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Introduction 
 
In the immediate post-surgical phase of recovery from kidney transplantation, 
vascular complications are infrequent but still one of the most likely causes of 
dysfunction and loss of the graft [1]. The most common complications include 
renal vein thrombosis, both major and minor arterial occlusion and acute 
tubular necrosis, often due to the periods of warm ischaemia prior to, and 
during, retrieval [2]. 
  
Traditionally, a combination of colour and spectral Doppler ultrasound and 
nuclear medicine, Technetium 99m-diethylene triamine penta-acetic acid (Tc-
DTPA) renogram, has been used to assess the vasculature in the new graft 
[3].  More recently, contrast enhanced ultrasound (CEUS) has emerged as a 
viable technique that can offer a high temporal and spatial resolution map of 
the microvasculature of the kidney [4, 5]. This provides new and more detailed 
information about the blood flow throughout the kidney and in particular areas 
of non-perfusion and is well established in native kidneys [6]. Several studies 
have described an increase in the detection of perfusion defects in kidney 
transplants when using CEUS compared to traditional techniques in both 
pathological and surgical arterial occlusion, suggesting that that perfusion 
defects may be more common than previously thought [7, 8]. 
 
The value of 3D ultrasound is well documented with regards to the detection 
of pathology and improving the accuracy of volume measurements using 
stacked contours to build up a model of the area being measured, being 
particularly useful in complex shapes [9,10]. Studies have shown that inter 
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and intra-operator variability is reduced in 3D volumetric studies of the 
kidneys with error margins of approximately 11% compared with 23% in 
standard ellipsoid measurements [8,9] Three dimensional CEUS enables the 
assessment of any abnormalities in the blood flow to a kidney transplant and 
to measure volumes of perfused tissue with greater accuracy than standard 
ultrasound and radio-isotope renograms [10]. Contrast enhanced ultrasound 
has been used extensively in liver, breast and cardiac applications but there 
are limited reports on renal transplant use [11].   
 
Although the increased accuracy of the assessment of renal perfusion is 
known to be increased using CEUS, the clinical relevance of these tiny 
perfusion defects is currently not known, although it has been suggested that 
they may be a cause for patients with “stuck” creatinine [12]. The aim of this 
study, therefore, was to assess the prevalence and size of perfusion defects 
in renal transplantation patients following surgery using 3D CEUS in an 
attempt to determine the significance of these perfusion defects on renal 
function. 
 
 
Method 
 
One hundred and five consecutive kidney transplant recipients were recruited 
prospectively regardless of donor type or post-surgical course.  Ethical 
approval was obtained from the local ethics committee and the trial was 
registered with the International Standard Randomised Controlled Trial 
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Number (ISRCTN) registry. Written informed consent was obtained from each 
participant to be included in the study.  
 
Following each patient’s routine ultrasound examination at day 1 post-surgery, 
each participant underwent a focused CEUS of the kidney transplant. This 
was performed using a standard dose of 2.4 ml Sonovue (Bracco, Milan, Italy) 
injected intravenously as a bolus, ideally in a peripheral cannula.  A central 
venous line was used on two occasions, however, due to poor peripheral 
access. The patients were scanned using an iu22 ultrasound system (Philips 
Healthcare, Bothell, USA) with vision 2011 software and an X6-1 matrix 
volume probe (broad bandwidth transducer operating between 1 and 6 MHz). 
A low mechanical index (0.05), power modulated technique with side by side, 
tissue suppressed, imaging was used for the contrast examination.   
 
Each kidney was observed for 1 minute to allow for the medullary filling phase 
to complete (Figure 1). It was subsequently assessed for perfusion defects 
using standard 2D contrast-specific ultrasound. An electronically steered 
volume data set was then acquired for offline quantification of any detected 
defect. This dataset was assessed for quality and inclusion of entire organ at 
time of scan.  The offline assessment was performed together by a 
sonographer and a radiologist (both >5 years’ experience with CEUS and 3D 
manipulation) using QLab ultrasound analysis software (Philips Healthcare, 
Bothell, USA). This allowed the block of data to be assessed in all three 
planes simultaneously using a multi-planar reconstruction format (MPR) and 
any quantification to be performed. Any areas of non-perfusion were 
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quantified using manually segmented stacked contours volume measurement 
of the entire kidney and of the focal area of non-perfusion. The percentage of 
total renal volume (TRV) that was non-perfused was then calculated (Figure 
1). 
 
Each patient was followed up for three months with regular inpatient and 
outpatient blood tests. Serum creatinine was measured at 1 day, 1 week, 2 
weeks, 1 month and 3 months post-surgery as well as estimated glomerular 
filtration rate (eGFR) at 1 month and 3 months post-surgery as an indicator of 
renal function. Local serum creatinine reference levels were 0.5 - 1.0 mg/dl 
(45-90 μmol/l) for women, 0.7 - 1.2 mg/dl (60-110 μmol/L) for men. The eGFR 
was calculated using the abbreviated MDRD equation [13]. 
  
Patients were separated into two independent groups based on the presence 
or absence of a perfusion defect. Mean differences between the groups on 
measures of renal function were then examined.  The likely magnitude of the 
true (population) mean difference was estimated using 90% confidence 
intervals and the probability of the true effect exceeding a smallest clinically 
important change of 26 µmol/L for creatinine and 5.0 ml/min/1.73m2 for eGFR 
was calculated using the methods of Hopkins et al [14].  
 
Analysis was performed using magnitude-based inference spreadsheets [15]. 
The smallest meaningful differences were taken from the renal association 
guidelines [14] as the difference between normal function and stage 1 acute 
kidney injury (AKI), and from discussions with the local transplant nephrology 
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team as the smallest clinical difference in eGFR which would require 
investigation.  Findings were considered clinically clear if the chance of benefit 
exceeded 25% while the chance of harm was less than 0.5%. If chance of 
harm exceeded 0.5%, the finding was deemed clinically unclear and more 
data needed [14]. 
 
A linear regression model was used to analyse whether the size of perfusion 
defect correlated with subsequent renal function using IBM SPSS statistics 
software, version 21 (IBM, UK). 
 
 
Results 
 
Three dimensional CEUS datasets of the entire kidney were achieved in all 
patients. 
 
Homogeneous global perfusion was seen in 81 patients. Focal areas of non-
perfusion were seen in 22 patients and a complete absence of enhancement 
was seen in two patients (100% TRV). No cases of acute cortical necrosis, 
with its idiosyncratic, peripheral rim infarction were seen in this patient group.   
The focal perfusion defects detected ranged in size from 0.2 to 76% TRV 
(mean 10.86 ±17.13 % TRV) (Figure 2).  Retrospective analysis of the 
operation records demonstrated ligated polar arteries in seven of the patients 
with focal perfusion defects. No ligated arteries were seen in the normal 
perfusion group. 
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The majority of perfusion defects were confined to the peripheral cortex of the 
poles of the graft (18/22, 81%), two patients had small focal cortical perfusion 
defects in the equatorial region (2/22, 9%), one (43% TRV) encompassed the 
entire upper pole and a portion of the equatorial region and one (76% TRV) 
encompassed the whole of the upper pole and equatorial region. 
 
Six patients were excluded from the longitudinal analysis as three underwent 
nephrectomies for graft ischaemia (the two patients with 100% perfusion loss 
and the patient with 76% perfusion loss) within the first two weeks after 
surgery, two patients were lost to follow up and one had primary non-function 
of the kidney. Creatinine was measured in all 99 remaining patients, of which 
20 perfusion defects were seen.  Estimated glomerular filtration rate was 
measured in 85 patients, of which 15 showed perfusion defects.  Estimated 
glomerular filtration rate measurements were not available in some follow up 
sites hence the reduction in sample size. 
 
Groups with non-surgically caused perfusion defects and those without 
perfusion defects were compared to assess any factors which might 
predispose transplanted kidneys to perfusion defects. No significant difference 
was seen in these groups (Table 1).  
 
There was no significant difference in factors which would change renal 
function in the initial post-surgical period. Nine patients had ATN (8.6%) (3 
with perfusion defect, 6 without), 7 (6.7%) had rejection (3 with perfusion 
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defect, 4 without) and two had both ATN and rejection (1 with perfusion 
defect, 1 without) within the first two weeks following surgery 
 
There was a difference between patients with and without perfusion defects in 
eGFR at 1 month (90% CI 2.7 to 19.2 ml/min/1.73m2) and 3 months (90% CI 
1.9 to 19.6 ml/min/1.73m2). There was an 88% and 86% chance respectively 
that the true differences exceeded a pre-determined clinical threshold 
magnitude of 5.0 ml/min/1.73m2. 
 
There was also a difference between patients with and without perfusion 
defects in creatinine at 3 months (90% CI -56 to -8 μmol/L) with a 66% chance 
that the true difference exceeded a predetermined clinical threshold of 26 
μmol/L (Table 2).  Differences between the groups in mean values for 
creatinine with reference to the smallest clinically meaningful difference at 1 
day (90% CI 42 ± 90, 62% beneficial, 10.6% harmful), 1 week (90% CI 34 ± 
110, 55% beneficial, 17.5% harmful), 2 weeks (90% CI 2.6 ± 66, 27.9% 
beneficial, 23.7% harmful) and 1 month (90% CI 10 ± 29, 18.6% beneficial, 
2.0% harmful) were clinically unclear. 
 
Little or no meaningful linear relationship was demonstrated between 
perfusion defect size and either creatinine at 1 day (R2=0.013, p = 0.651), 1 
week (R2=0.032, p =0.480), 2 weeks (R2=0.036, p= 0.0452) and 1 month 
(R2=0.139, p= 0.127), or eGFR at 1 month (R2=0.101, p = 0.289), but there 
was a high degree of correlation with eGFR at 3 months (R2= 0.34, p= 0.038, 
66% likely clinically beneficial) and a very high correlation with 3 month 
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creatinine (R2= 0.64, p < 0.000, 99% likely clinically beneficial) (Table 3).  
Confidence intervals for the linear regression slope suggested that at 3 
months, a 4.11±0.76 μmol/L increase in creatinine and a 0.89 ±0.38 
ml/min/1.73m2 reduction in eGFR would be seen for each 1% increase in 
perfusion defect size. 
 
 
Discussion 
 
The aim of this study was to assess the prevalence and size of vascular 
abnormalities in renal transplantation patients following surgery using 3D 
CEUS in an attempt to determine the clinical relevance of the tiny perfusion 
defects which are seen when using this technique, on renal function.  In this 
study 22 focal defects were seen in 105 patients (21% cases), and the 
majority were pathological rather than surgical (17 vs 7 cases), suggesting 
that kidney transplant perfusion defects are more prevalent than previously 
thought [17].  
 
All perfusion defects were wedge shaped cortical infarctions or cresent 
shaped polar infarctions rather than the rare but significant finding of 
peripheral rim ischaemia seen in acute cortical necrosis.  
These perfusion defects are likely to be clinically meaningful with increased 
creatinine and reduced eGFR seen at 3 months post-surgery in patients with 
a perfusion defect. Three-dimensional defect size quantification also 
correlated with the subsequent serum creatinine and eGFR at 3 months post-
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surgery, which should lead to a better understanding of the likely function of 
the kidney in patients with these perfusion defects. 
 
Large perfusion defects have previously been detected using ultrasound and 
Tc-DTPA [18]. However, smaller defects, almost all of which were peripheral 
and polar in position in this study, are difficult to assess as poor Doppler 
angle, low velocity flow in the peripheral cortex and edge dropout on 
ultrasound and the poor spatial resolution and static position in Tc-DTPA all 
play a factor in confidently making the diagnosis [3]. The resolution and 
dynamic nature of the CEUS made it relatively straightforward to detect even 
small areas of non-perfusion in this and similar studies [6]. 
 
The lack of a stable, unvarying initial post-surgical course makes it 
unsurprising that there was little correlation between perfusion defects and 
kidney function seen within the first few weeks following surgery, and that the 
interval for the correlation coefficient was broad. Large variability was 
observed in serum creatinine and eGFR measurement obtained at the initial 
follow up points, illustrating the variability often seen in function of early kidney 
transplantation [19].  This variability was reduced at the later follow up time 
points. This is likely to be due to a number of factors including prolonged 
retrieval, post-surgical complications, biopsies and biopsy complications and 
delayed graft function.  Delayed function is common, lasting for between a few 
days to several months, and is caused by a variety of pre-, peri- and post-
transplant factors including ischaemic time, fluid management, age of donor 
and pharmacological regimes [20].  
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The highly significant correlation seen between perfusion defect size and drop 
in renal function at three months is understandable as there is less functional 
tissue and there are fewer functioning nephrons. This has an impact on both 
the acute and long term function, as there are changes in the haemodynamics 
of the kidney which can cause and perpetuate chronic dysfunction [21]. The 
greater the size of the perfusion defect, the greater the loss of nephrons 
would be. In the present study, perfusion defect size and 3 month creatinine 
and eGFR were found to have B values of 4.1 ±0.76 μmol/L and -0.89 ±0.38 
ml/min/1.73m2. In real terms, this means that we can expect a patient with a 
modest perfusion defect of 10% TRV to present in clinic at 3 months post-op 
with serum creatinine between 33.5 and 48.7 μmol/L higher than if they had 
no defect at all. Patients with a 10% TRV perfusion defect would be expected 
to present to clinic at 3 months with an eGFR of between 5.1 and 12.7 
ml/min/1.73m2 lower.  
 
Magnitude-based inference is a good way of determining the clinical 
usefulness of any test [13]. In this case, justifiable smallest clinically 
meaningful changes in serum creatinine (26 μmol/L) and eGFR (5.0 
ml/min/1.73m2) were used to determine the proportion of the confidence 
interval which lies above this value. This gives a likelihood that the result will 
be clinically beneficial, trivial or harmful. In this study, it was seen that not only 
will the presence of a perfusion defect result in a statistically significant rise in 
serum creatinine and eGFR at 3 months, but it is likely to produce a clinically 
meaningful change (67% and 86% likelihood, respectively). 
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These findings should modify expectation from the transplant team when 
follow up is being performed. Allowances can, therefore, be made for “stuck” 
creatinine just above normal values if a suitably sized perfusion defect was 
observed after surgery. This could prevent or reduce the number of biopsies 
being performed to explain these borderline results, reducing the associated 
risks of complications, quoted as between 0.06 and 13% [22] with this 
procedure and cost, both procedural and during overnight stays. 
 
 
Limitations 
 
The sample size in this study is quite small with 105 participants and 
subsequently only 22 perfusion defects were seen. While a 3D stacked 
contours technique was used to minimise operator variability this is still a 
recognised source of error (+/- 10%) [9] in measuring the size of the perfusion 
defects. 
 
 
Conclusion 
 
In conclusion, focal perfusion defects were more common than expected 
occurring in 21% of patients and ranged in size from 0.2 - 76%. CEUS 
allowed detection of tiny perfusion defects as small as 0.2% TRV. An increase 
in creatinine at 3 months and reductions in eGFR at 1 and 3 months post-
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surgery were seen in patients with a perfusion defects in their kidney 
transplant and these changes are likely to be at a clinically meaningful level.  
The magnitude of the perfusion defect correlates with the degree of change in 
serum creatinine and eGFR seen at 3 month.  This correlation is also highly 
likely to be clinically meaningful. This may be useful in informing clinician 
expectations of kidney function following surgery. 
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Table 1 
 
Table 1 demonstrating average values of population and surgical factors 
involved in kidney transplantation between patients with a non-surgically 
caused perfusion defect and those with no perfusion defect. 
 
Factor Non-surgical 
perfusion defect 
group averages 
(n=16) 
No perfusion 
defect group 
averages (n=77) 
Statistical 
divergence (t-
test) 
Recipient body 
mass index 
28.90 28.15 t = -0.014, df 95, 
p = 0.495 
Donor Age 
(years) 
47.13 48.49 t = -0.762, df 96, 
p = 0.224 
Donor type 9 DCD (56%) 41 DCD (53%)  
 3 DBD (19%) 12 DBD (16%)  
 4 LD (25%) 24 LD (31%)  
Warm storage 
time (minutes) 
16.07 10.54 t = -1.270, df 97, 
p = 0.104 
Cold storage 
time (minutes) 
874.07 719.85 t = -0.030, df 96, 
p = 0.488 
Number of 
donor arteries 
1.5 1.37 t = -0.002, df 97, 
p = 0.499 
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Table 2 
 
 
Table 2: Magnitude-based clinical inference based on the smallest meaningful 
change in kidney function results.  
  
Compared Groups 
Mean difference with 
90% confidence limits 
Zα/2 * σ/√(n) 
Clinical inference a 
Creatinine day 1 
with and without  
perfusion defect 
42 ± 90 
Possibly beneficial (61.6%) 
Possibly trivial (27.8%) 
Unlikely harmful (10.6%) 
Creatinine 1 week 
with and without  
perfusion defect 
34 ± 110 
Possibly beneficial (55%) 
Possibly trivial (27.5%) 
Unlikely harmful (17.5%) 
Creatinine 2 week 
with and without  
perfusion defect 
2.6 ± 66 
Possibly beneficial (27.9%) 
Possibly trivial (48.4%) 
Unlikely harmful (23.7%) 
Creatinine 1 month 
with and without  
perfusion defect 
10 ± 29 
Unlikely beneficial (18.6%) 
Unlikely Trivial (79.4%) 
Very unlikely harmful (2.0%) 
Creatinine 3 month 
with and without  
perfusion defect 
32 ± 24 
Probably beneficial (66%) 
Possibly trivial (34%) 
Most unlikely harmful (0.0%) 
eGFR 1 month with 
and without  
perfusion defect 
11 ± 8.2 
Likely beneficial (88.2%) 
Unlikely trivial (11.7 %) 
Most unlikely harmful (0.1%) 
eGFR 3 month with 
and without  
perfusion defect 
11 ± 9 
Likely beneficial (85.9%) 
Unlikely trivial (13.9%) 
Very unlikely harmful (0.2%) 
a with reference to smallest worthwhile change of 26 micromol/L creatinine and 
5.0 mls/min/1.73m2 eGFR 
Paper accepted by European Radiology 
Table 3 
 
Table 3: Magnitude-based inference of clinical usefulness in predicting 
changes to renal function at 1 and 3 month following surgery based on 
perfusion defect size with reference to a high correlation of 0.5.  
 
  
Compared Groups Mean correlation 
coefficient with 90% 
confidence limits 
Clinical inference a 
Creatinine 1 month – 
perfusion defect size 
0.37 ± 0.32 Unlikely beneficial (24.7%) 
Likely Trivial (75.3 %) 
Creatinine 3 month – 
perfusion defect size 
0.8 ± 0.14 Very likely beneficial (99.1%) 
Very unlikely trivial (0.9%) 
eGFR 1 month – 
perfusion defect size 
0.32 ± 0.39 Unlikely beneficial (21.4%) 
Likely trivial (78.5 %) 
Very unlikely Harmful (0.1 %) 
eGFR 3 month – 
perfusion defect size 
0.58 ± 0.3 Probably beneficial (65.8%) 
Possibly trivial (34.2%) 
a with reference to a high correlation of 0.5. 
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Figure 1 
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Figure 2 
 
 
 
Figure 2: Distribution of perfusion defects seen in kidney transplants 
measured in percentage of total renal volume. 
 
